These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31040154)

  • 1. MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.
    Hansen LJ; Sun R; Yang R; Singh SX; Chen LH; Pirozzi CJ; Moure CJ; Hemphill C; Carpenter AB; Healy P; Ruger RC; Chen CJ; Greer PK; Zhao F; Spasojevic I; Grenier C; Huang Z; Murphy SK; McLendon RE; Friedman HS; Friedman AH; Herndon JE; Sampson JH; Keir ST; Bigner DD; Yan H; He Y
    Cancer Res; 2019 Jul; 79(13):3383-3394. PubMed ID: 31040154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
    Chen ZH; Olopade OI; Savarese TM
    Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing Hypoxia-inducible factor 1 alpha activity.
    Huang H; Shah H; Hao J; Lin J; Prayson RA; Xie L; Bao S; Chakraborty AA; Jankowsky E; Zhao J; Yu JS
    Neuro Oncol; 2024 Aug; 26(8):1388-1401. PubMed ID: 38456228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells.
    Hori H; Tran P; Carrera CJ; Hori Y; Rosenbach MD; Carson DA; Nobori T
    Cancer Res; 1996 Dec; 56(24):5653-8. PubMed ID: 8971171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
    Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors].
    Wang SN; Wang W; Zhang XW; Zhang YQ; Xiong YL; Liu L; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):439-445. PubMed ID: 38678323
    [No Abstract]   [Full Text] [Related]  

  • 7. MTAP loss: a possible therapeutic approach for glioblastoma.
    Patro CPK; Biswas N; Pingle SC; Lin F; Anekoji M; Jones LD; Kesari S; Wang F; Ashili S
    J Transl Med; 2022 Dec; 20(1):620. PubMed ID: 36572880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting
    Hu Q; Qin Y; Ji S; Shi X; Dai W; Fan G; Li S; Xu W; Liu W; Liu M; Zhang Z; Ye Z; Zhou Z; Yang J; Zhuo Q; Yu X; Li M; Xu X
    Cancer Res; 2021 Oct; 81(19):4964-4980. PubMed ID: 34385182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma.
    Wu Q; Berglund AE; MacAulay RJ; Etame AB
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
    Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
    Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
    Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY
    Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine.
    Barekatain Y; Ackroyd JJ; Yan VC; Khadka S; Wang L; Chen KC; Poral AH; Tran T; Georgiou DK; Arthur K; Lin YH; Satani N; Ballato ES; Behr EI; deCarvalho AC; Verhaak RGW; de Groot J; Huse JT; Asara JM; Kalluri R; Muller FL
    Nat Commun; 2021 Jul; 12(1):4228. PubMed ID: 34244484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
    Kaur H; Ali SZ; Huey L; Hütt-Cabezas M; Taylor I; Mao XG; Weingart M; Chu Q; Rodriguez FJ; Eberhart CG; Raabe EH
    Cancer Lett; 2016 Jul; 377(1):55-64. PubMed ID: 27102002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization.
    Hansen LJ; Yang R; Roso K; Wang W; Chen L; Yang Q; Pirozzi CJ; He Y
    Sci Rep; 2022 Mar; 12(1):4183. PubMed ID: 35264604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
    Shin HJ; Lee S; Jung HJ
    J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
    Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.